Insiders Advisor
  • Stocks
  • World News
  • Business
  • Politics
  • Stocks
  • World News
  • Business
  • Politics

Insiders Advisor

Politics

Dr. Oz becomes next head of Medicare and Medicaid Services following approval from full Senate

by April 3, 2025
April 3, 2025
Dr. Oz becomes next head of Medicare and Medicaid Services following approval from full Senate

Dr. Mehmet Oz will serve as the next administrator of the Centers for Medicare and Medicaid Services after the full Senate voted along party lines to confirm his nomination on Thursday. 

The former daytime TV doctor turned politician will be in charge of nearly $1.5 trillion in federal healthcare spending. His duties will entail overseeing Medicare, Medicaid and the Children’s Health Insurance Program (CHIP), including directing decisions related to how the government covers procedures, hospital stays and medication, as well as the reimbursement rates at which healthcare providers get paid for their services.   

Medicare is a federal healthcare program for seniors aged 65 and up, and currently provides coverage to about 65 million Americans, according to the Center for Medicare Advocacy. Medicaid, a public health assistance program for people with low incomes, covers roughly 72 million Americans, according to Medicaid.gov. Meanwhile, CHIP, which provides free or low-cost health coverage for eligible low-income children and family members, assists around 7.2 million individuals. 

A graduate of Harvard University, Oz received medical and business degrees from the University of Pennsylvania. He is a former heart surgeon who saw his fame rise through his appearances on daytime television, including ‘The Oprah Winfrey Show,’ and 13 seasons of ‘The Dr. Oz Show.’

Oz later transitioned into politics, launching an unsuccessful bid for Pennsylvania’s open Senate seat in 2022. He lost to John Fetterman, then the state’s lieutenant governor.

‘Dr. Oz has a strong desire to modernize CMS and encourage healthy lifestyles for all Americans, including by focusing on the underlying causes of chronic disease and implementing innovative technologies,’ Senate Finance Committee Chairman Sen. Mike Crapo, R-Idaho, said Thursday.

Crapo, who led Oz’s nomination process at the committee level, commended Oz for his ‘diligence and accessibility’ throughout the process, including his willingness to answer ‘hundreds’ of questions for the record.

Those questions came from both Republicans and Democrats. They included asking about Oz’s stance on abortion, transgender medical treatments, Medicare privatization, prescription drug pricing and more. Potential financial conflicts of interest were also a concern among Democratic lawmakers throughout Oz’s confirmation process. Oz has committed to divesting any holdings that may pose an issue. 

Thursday’s confirmation comes as the Trump administration continues to work to finalize the rest of its political appointments, including notably the president’s pick to be the next United Nations ambassador and his pick for director of the Consumer Financial Protection Bureau. 

Per The Washington Post’s ‘political appointee tracker,’ there are currently still 233 nominees being considered by the Senate.

This post appeared first on FOX NEWS
previous post
Waltz’s Signal chat woes snowball as Trump admin defends national security advisor
next post
Trump confirms National Security Council firings as Waltz’s Signal chat woes snowball

Related Posts

Take it from this Muslim: Peace depends on...

May 14, 2025

Johnson to sidestep GOP rebels on government funding,...

September 24, 2024

CIA being restructured to eliminate ‘well-documented politicization’: Ratcliffe

April 30, 2025

Lawmakers eye ‘low hanging fruit’ for government efficiency...

December 18, 2024

Focus group reacts to Trump, Harris faceoff over...

September 11, 2024

Michael Bloomberg becomes 2nd largest Harris donor behind...

October 29, 2024

Iran violently clamps down on Christians amid reports...

March 3, 2024

New polls show Biden leaving office with approval...

January 15, 2025

Bipartisan letter warns Gabbard new UK order for...

February 13, 2025

Happy birthday to America’s first presidential centenarian

October 1, 2024

    Fill Out & Get More Relevant News


    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Latest News

    • Iran regime escalates repression toward ‘North Korea-style model of isolation and control’

      July 4, 2025
    • This July 4th, a family waits: American hostage’s father pleads for son’s freedom from Hamas terrorists

      July 4, 2025
    • President Trump to honor Iran strike flight team at the White House

      July 4, 2025
    • North Korea lashes out after Trump DOJ exposes massive IT infiltration scheme

      July 4, 2025
    • Saudi defense minister secretly meets with Trump to discuss Iran de-escalation, Israel: sources

      July 4, 2025
    • Trump administration swarms SCOTUS with emergency requests and sees surprising success

      July 4, 2025

    Categories

    • Business (1,295)
    • Politics (6,282)
    • Stocks (904)
    • World News (460)
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: insidersadvisor.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 insidersadvisor.com | All Rights Reserved